Novo Nordisk and Eli Lilly are moving to end compounding of their medicines for good
Por ltimo, la acetil L-carnitina suministra energa a los nervios y permite la produccin de neurotransmisores cruciales para la salud mental, como acetilcolina, GABA y glutamato
Photosensitivity is not listed among known adverse effects in the MHRA-approved Summary of Product Characteristics
However, the ATTAIN-MAINTAIN trial showed that patients can switch from injectable tirzepatide to oral orforglipron (once approved) while largely maintaining their weight loss
Both remain on the FDAs restricted compounding list as of May 2026
It has also launched its first GLP-1 product, liraglutide, in markets such as the UK, Australia, Saudi Arabia and South Africa, and has signed two GLP-1 contracts to support future launches